Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Neoadjuvant Therapy × abiraterone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 3 Neoplasm Metastasis 2 Prostatic Neoplasms, Castration-Resistant 1 Neoadjuvant Therapy 1 Castration-resistant Prostate Cancer 1

Interventions

pembrolizumab 1 pamiparib 1 abiraterone 1 Prednisone 1 Folfox protocol 1 Fluorouracil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05376722 2023-01-05

A Study of Pamiparib Combined With Abiraterone Acetate in Neoadjuvant Treatment of Prostate Cancer

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Phase 2 Unknown

Neoadjuvant Therapy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡